REPLY
Reply: Tuberculin Skin Testing
Jacques Pouchot, MD;
Anne Grasland, MD; and
Philippe Vinceneux, MD
15 August 1997 | Volume 127 Issue 4 | Page 334
IN RESPONSE:
Our study was designed specifically to assess the reliability of the measurement of skin induration obtained after tuberculin skin testing. We could not agree more with the recommendations of Dr. Flynn; of course, as stated in our article, the proper administration of the tuberculin skin test according to the Mantoux technique was a prerequisite of our study. It is undoubtedly essential to administer the tuberculin skin test in the proper way. Moreover, in addition to administering the test correctly and measuring the skin induration carefully, it should be emphasized that the interpretation of the tuberculin skin test result should consider the individual clinical context and the official published recommendations on tuberculosis [1]. Again, although useful, the tuberculin skin test remains an imperfect diagnostic tool and should not replace clinical judgment.
We apologize to Longfield and colleagues for having omitted their study from our article and agree that the picture of the ballpoint method they presented may be useful to readers [2]. As in our study, interobserver reliability appreciated by global
coefficients indicated good agreement (0.82 for the ballpoint method and 0.84 for palpation). Unfortunately, Longfield and colleagues did not use the graphical analysis recommended by Bland and Altman, which provides a more meaningful representation of the level of variation [3]. Although we agree that the overall percentage of patients who would have reclassification of their tuberculin skin test result is rather low (7% between the ballpoint and palpation methods by the same reader in Longfield and colleagues' study and 12% to 17.4% in our study according to the technique of measurement and the interobserver or intraobserver analysis), misclassification may be much more common when measurements are close to the cutoff point that separates negative from positive results.
|
Author and Article Information
|
|---|
Hopital Louis Mourier; 92700 Colombes, France
1. Bass JB Jr, Farer LS, Hopewell PC, O'Brien R, Jacobs RF, Ruben F, et al. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and the Centers for Disease Control and Prevention. Am J Respir Crit Care Med. 1994; 149:1359-74.[Abstract]
2. Longfield JN, Margileth AM, Golden SM, Lazoritz S, Bohan JS, Cruess DF. Interobserver and method variability in tuberculin skin testing. Pediatr Infect Dis. 1984; 3:323-6.
3. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986; 1:307-10.
About Letters
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
Include no more than 300 words of text, three authors, and five references
Type with double-spacing
Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.